Tumor-targeted gene delivery of tumor necrosis factor-α induces tumor necrosis and tumor regression without systemic toxicity (original) (raw)
Behr JP . Gene transfer with synthetic cationic amphiphiles: prospects for gene therapy Bioconjug Chem 1994 5: 382–389 Review ArticleCASPubMed Google Scholar
Felgner JH, Kumar R, Sridhar CN et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations J Biol Chem 1994 269: 2550–2561 CASPubMed Google Scholar
Wagner E, Zatloukal K, Cotton M et al. Coupling of adenovirus to transferrin–polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes Proc Natl Acad Sci USA 1992 89: 6099–6103 ArticleCASPubMedPubMed Central Google Scholar
Boussif O, Lezoulach F, Zanta MA et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo — polyethylenimine Proc Natl Acad Sci USA 1995 92: 7297–7301 ArticleCASPubMedPubMed Central Google Scholar
Kircheis R, Schüller S, Brunner S et al. Polycation-based DNA complexes for tumor-targeted gene delivery in vivoJ Gene Med 1999 1: 111–120 ArticleCASPubMed Google Scholar
Ogris M, Brunner S, Schüller S et al. PEGylated DNA/Transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery Gene Ther 1999 6: 595–605 ArticleCASPubMed Google Scholar
Kircheis R, Wightman L, Schreiber A et al. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application Gene Ther 2001 8: 28–40 ArticleCASPubMed Google Scholar
Carswell EA, Old LJ, Kassel RL et al. An endotoxin-induced serum factor that causes necrosis of tumors Proc Natl Acad Sci USA 1975 72: 3666–3670 ArticleCASPubMedPubMed Central Google Scholar
Watanabe N, Niitsu Y, Umeno H et al. Toxic effect of tumor necrosis factor on tumor vasculature in mice Cancer Res 1988 48: 2179–2183 CASPubMed Google Scholar
Renard N, Lienard D, Lespagnard L et al. Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNF alpha) Int J Cancer 1994 57: 656–663 ArticleCASPubMed Google Scholar
Van de Wiel PA, Bloksma N, Kuper CF et al. Macroscopic and microscopic early effects of tumor necrosis factor on murine MethA sarcoma, and relation to curative activity J Pathol 1989 157: 65–73 ArticleCASPubMed Google Scholar
Shalaby MR, Aggarwal BB, Rinderknecht E et al. Activation of human polymorphonuclear neutrophil functions by interferon-γ and tumor necrosis factor J Immunol 1985 135: 2069–2073 CASPubMed Google Scholar
Scheurich P, Thoma B, Ücer U et al. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha mediated enhancement of T cell responses J Immunol 1987 138: 1786–1790 CASPubMed Google Scholar
Bendtzen K . Interleukin-1, interleukin-6 and tumor necrosis factor in infection, inflammation and immunity Immunol Lett 1988 19: 183–192 ArticleCASPubMed Google Scholar
Sugarman BJ, Aggarwal BB, Hass PE et al. Recombinant tumor necrosis factor-α: effect on proliferation of normal and transformed cells in vitroScience 1985 230: 943–945 ArticleCASPubMed Google Scholar
Beutler B, Milsark IW, Cerami A . Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin Science 1985 229: 869–871 ArticleCASPubMed Google Scholar
Beutler B, Cerami A . Cachectin and tumor necrosis factor as two sides of the same biological coin Nature 1986 320: 584–588 ArticleCASPubMed Google Scholar
Anderson JA, Miller FN, Sims DE et al. Tumor necrosis factor causes microvascular protein leakage independently of neutrophils or mast cells J Surg Res 1994 56: 485–490 ArticleCASPubMed Google Scholar
Kunstle G, Hentze H, Germann PG et al. Concanavalin A hepatotoxicity in mice: tumor necrosis factor–mediated organ failure independent of caspase-3–like protease activation Hepatology 1999 30: 1241–1251 ArticleCASPubMed Google Scholar
Kircheis R, Milleck J, Korobko VG et al. Biological activity of mutants of human tumour necrosis factor-alpha Immunology 1992 76: 433–438 CASPubMedPubMed Central Google Scholar
Van Zee KJ, Stackpole SA, Montegut WJ et al. A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon J Exp Med 1994 179: 1185–1191 ArticleCASPubMed Google Scholar
Eggermont AM, Schraffordt Koops H, Klausner JM et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience Ann Surg 1996 224: 756–764 ArticleCASPubMedPubMed Central Google Scholar
Vrouenraets BC, Kroon BB, Ogilvie AC et al. Absence of severe systemic toxicity after leakage-controlled isolated limb perfusion with tumor necrosis factor-alpha and melphalan Ann Surg Oncol 1999 6: 405–412 ArticleCASPubMed Google Scholar
Goula D, Benoist C, Mantero S et al. Polyethylenimine-based intravenous delivery of transgenes to mouse lung Gene Ther 1998 5: 1291–1295 ArticleCASPubMed Google Scholar
Whitemore MA, Li S, Huang L . LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth Gene Ther 1999 6: 1867–1875 Article Google Scholar
Kircheis R, Milleck J, Korobko VG et al. Differences in the biological activity of TNFα and TNFβ correlate with their different abilities for binding to the target cells Eur Cytokine Netw 1992 3: 381–390 CASPubMed Google Scholar
Sherman ML, Spriggs DR, Arthur KA et al. Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism J Clin Oncol 1988 6: 344–350 ArticleCASPubMed Google Scholar
Lenk H, Tanneberger S, Müller U et al. Phase II clinical trial of high-dose recombinant human tumor necrosis factor Cancer Chemother Pharmacol 1989 24: 391–392 ArticleCASPubMed Google Scholar
Creaven PJ, Brenner DE, Cowens JW et al. A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days Cancer Chemother Pharmacol 1989 23: 186–191 CASPubMed Google Scholar
Mizuguchi H, Nakagawa T, Toyosawa S et al. Tumor Necrosis Factor α–mediated tumor regression by the in vivo transfer of genes into the artery that leads to tumors Cancer Res 1998 58: 5725–5730 CASPubMed Google Scholar
Marr RA, Hitt M, Muller WJ et al. Tumour therapy in mice using adenovirus vectors expressing human TNFα Int J Oncol 1998 12: 509–515 CASPubMed Google Scholar
Kircheis R, Wagner E . Polycation/DNA complexes for in vivo gene delivery Gene Ther Regul 2000 1: 95–114 ArticleCAS Google Scholar
Gerlowski LE, Jain RK . Microvascular permeability of normal and neoplastic tissue Microvasc Res 1986 31: 288–305 ArticleCASPubMed Google Scholar
Hobbs SK, Monsky WL, Yuan F et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment Proc Natl Acad Sci USA 1998 95: 4607–4612 ArticleCASPubMedPubMed Central Google Scholar
Papahadjopoulos D, Allen TM, Gabizon A et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy Proc Natl Acad Sci USA 1991 88: 11460–11464 ArticleCASPubMedPubMed Central Google Scholar
Wagner E, Curiel D, Cotten M . Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor mediated endocytosis Adv Drug Dev Rev 1994 14: 113–135 ArticleCAS Google Scholar
Kircheis R, Kichler A, Wallner G et al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery Gene Ther 1997 4: 409–418 ArticleCASPubMed Google Scholar